Samer Haidar

Preclinical Efficacy of the MDM2 Inhibitor RG7112 in <i>MDM2</i> -Amplified and <i>TP53</i> Wild-type Glioblastomas

Maïté Verreault, Charlotte Schmitt, Lauriane Goldwirt et al. · Clinical Cancer Research · 2015 · 112 citations · Full text

Medicine, Oncology, Pharmacology +15

Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate

Mark M. Stevens, Cécile L. Maire, Nigel Chou et al. · Nature Biotechnology · 2016 · 105 citations · Full text

Medicine, Cancer Biology, Oncology +15

Effects of novel 17α-hydroxylase/C17, 20-lyase (P450 17, CYP 17) inhibitors on androgen biosynthesis in vitro and in vivo

Samer Haidar, Peter B. Ehmer, Stephan Barassin et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2003 · 103 citations

Life Sciences, Endocrinology, Pharmacology +16

Synthesis and Evaluation of Novel Steroidal Oxime Inhibitors of P450 17 (17α-Hydroxylase/C17−20-Lyase) and 5α-Reductase Types 1 and 2

Rolf W. Hartmann, Markus Hector, Samer Haidar et al. · Journal of Medicinal Chemistry · 2000 · 86 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Inhibition of CYP 17, a New Strategy for the Treatment of Prostate Cancer

Rolf W. Hartmann, Peter B. Ehmer, Samer Haidar et al. · Archiv der Pharmazie · 2002 · 60 citations

Medicine, Oncology, Pharmacology +17